Cellular and Molecular Underpinnings of Mood Stabilization, and Strategies to Develop Improved Therapeutics

Molecular and cellular mechanisms underlying mood stabilization in bipolar disorder: implications for the development of improved therapeutics

• H K Manji
• C A Zarate

What makes a drug a primary mood stabilizer?

• P E Keck Jr
• S L McElroy
• M Tohen

Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission

• C A Stewart
• I C Reid

Delayed pharmacological effects of antidepressants

• A Frazer
• S Benmansour

Synaptic plasticity and mood disorders

• R S Duman

Mood stabilizers, glycogen synthase kinase-3β and cell survival

• R S Jope
• G N Bijur

PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

• H K Manji
• G Chen

Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents

• F P Bymaster
• C C Felder

Can brain-imaging studies provide a ‘mood stabilizer signature?’

• J C Soares

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

• J H Krystal
• G Sanacora
• G F Mason

Author index to Volume 7 Supplement 1

Keyword index to Volume 7 Supplement 1